Skip to main content
. 2022 Jan 11;48(2):294–302. doi: 10.1590/S1677-5538.IBJU.2021.0472

Table 3. Oncologic history and T2-weighted imaging analysis evaluated by groups.

Variable Typical adenomas N (%) Lipid poor adenomas N (%) Non-adenomas N (%) Total N (%) p-value
Oncologic history <0.001
No 88 (89.8) 12 (80.0) 3 (30.) 103 (83.7)
Yes 10 (10.2) 3 (20.0) 7 (70.0) 20 (16.3)
T2 signal <0.001
Homogeneous 91 (92.9) 10 (66.7) 2 (20.0) 103 (83.7)
Heterogeneous 7 (7.1) 5 (33.3) 8 (80.0) 20 (16.3)
T2 signal <0.001
Hyposignal 94 (95.9) 10 (66.7) 5 (50.0) 109 (88.6)
Hypersignal 4 (4.1) 5 (33.3) 5 (50.0) 14 (11.4)
Total 98 (100.0) 15 (100.0) 10 (100.0) 123 (100.0)

Chi-square test